Lee Golden serves as the Executive Vice President and Chief Medical Officer at PTC Therapeutics Inc., a biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for rare disorders. In his role, Dr. Golden oversees the clinical development and medical affairs of PTC's portfolio, driving the company's mission to provide life-changing therapies to patients with unmet medical needs. His leadership is instrumental in advancing PTC's pipeline and ensuring the successful execution of clinical trials. Dr. Golden brings a wealth of experience to PTC Therapeutics, having spent over two decades in the biopharmaceutical industry. Prior to joining PTC, he held several senior leadership positions at major pharmaceutical companies, where he played a key role in the development and approval of multiple innovative therapies. Dr. Golden's expertise spans various therapeutic areas, including rare diseases, oncology, and neurology. He has a proven track record of building and leading high-performing teams, fostering collaboration across functions, and navigating the complex regulatory landscape to bring new medicines to market. Throughout his career, Dr. Golden has been recognized for his contributions to the field of medicine and his commitment to improving patient outcomes. He is a respected thought leader and frequently engages with the medical community through presentations at scientific conferences and publications in peer-reviewed journals. At PTC Therapeutics, Dr. Golden continues to drive the company's scientific excellence and innovation, working tirelessly to advance the development of transformative treatments for patients with rare disorders.